Transcatheter aortic valve implantation in pure aortic regurgitation: Hemodynamic and echocardiographic findings in bioprosthesis vs. native valve.
Lazzaro ParaggioFrancesco BurzottaFrancesca GrazianiCristina AurigemmaEnrico RomagnoliDaniela PedicinoGabriella LocorotondoErica MencarelliRosa LilloPiergiorgio BrunoDomenico LaezzaNicole GiambussoAntonella LombardoCarlo TraniPublished in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2022)
Successful TAVI induces a striking hemodynamic impact with major structural (reverse remodeling) consequences in patients with pure AR caused by both bioprosthesis degeneration or NV disease. In the immediate postrelease phase, VIV patients might exhibit a more pronounced early LV contractile and structural benefit.
Keyphrases
- aortic valve
- transcatheter aortic valve implantation
- aortic stenosis
- ejection fraction
- aortic valve replacement
- transcatheter aortic valve replacement
- left ventricular
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- prognostic factors
- skeletal muscle
- pulmonary hypertension
- left atrial
- coronary artery
- patient reported outcomes